Results 141 to 150 of about 47,032 (177)
Some of the next articles are maybe not open access.

Adverse reactions to radiopharmaceuticals: liver radiopharmaceuticals

Nuclear Medicine Communications, 2021
Radiopharmaceuticals are radioactive compounds used in nuclear medicine, consisting of a radioactive moiety and a pharmaceutical part. Radiopharmaceuticals are used for diagnosis (predominantly) and therapy (to a lesser extent). Adverse drug reactions are undesirable, unexpected, often harmful drug responses that occur when the drug is administered in ...
Humeyra, Battal, Asuman Yekta, Ozer
openaire   +2 more sources

The Impact of Radiopharmaceutical Therapy on Renal Function.

Seminars in nuclear medicine, 2022
Radiopharmaceuticals used for cancer therapy are highly selective, designed to kill malignant cells and spare healthy tissues. Side effect rates are generally less than other treatments, but it is still the utmost concern to minimize normal organ ...
E. Park, S. Graves, Y. Menda
semanticscholar   +1 more source

Dosimetry for Optimized, Personalized Radiopharmaceutical Therapy.

Seminars in Radiation Oncology, 2021
Radiopharmaceutical therapy (RPT) has grown rapidly over the last decade for treatment of numerous cancer types. Dosimetric guidance, as with other radiotherapy modalities, has benefitted patients by reducing the incidence of side effects and improving ...
S. Graves, R. Hobbs
semanticscholar   +1 more source

Role of Artificial Intelligence in Theranostics:: Toward Routine Personalized Radiopharmaceutical Therapies.

PET Clinics, 2021
We highlight emerging uses of artificial intelligence (AI) in the field of theranostics, focusing on its significant potential to enable routine and reliable personalization of radiopharmaceutical therapies (RPTs).
J. Brosch-Lenz   +7 more
semanticscholar   +1 more source

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology.

The Lancet Oncology
This paper is the first of a Series on theranostics that summarises the current landscape of the radiopharmaceutical sciences as they pertain to oncology.
S. Lapi   +18 more
semanticscholar   +1 more source

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics.

The Lancet Oncology
Although the promise of radionuclides for the diagnosis and treatment of disease was recognised soon after the discovery of radioactivity in the late 19th century, the systematic use of radionuclides in medicine only gradually increased over the ...
A. Scott   +17 more
semanticscholar   +1 more source

“Naked” radiopharmaceuticals

International Journal of Radiation Oncology*Biology*Physics, 2006
The term "naked" radiopharmaceuticals, more appropriately, "unbound" radiopharmaceuticals, refers to any radioisotope used for clinical research or clinical purposes that is not attached to a chemical or biological carrier, and that localizes in various tissues because of a physiologic or chemical propensity/affinity, or secondary to focal anatomic ...
openaire   +2 more sources

On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion.

Nuclear Medicine and Biology, 2020
Radiochemical conversion is an important term to be included in the "Consensus nomenclature rules for radiopharmaceutical chemistry". Radiochemical conversion should be used to define reaction efficiency by measuring the transformation of components in a
M. Herth   +25 more
semanticscholar   +1 more source

Radiopharmaceuticals

Journal of Pharmaceutical Sciences, 1967
W, Wolf, M, Tubis
openaire   +4 more sources

Home - About - Disclaimer - Privacy